Mahkam Zanganeh - 08 Mar 2023 Form 4/A - Amendment Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Co-CEO & President, Director
Signature
/s/ Mahkam Zanganeh
Issuer symbol
SMMT
Transactions as of
08 Mar 2023
Net transactions value
+$24,703,396
Form type
4/A - Amendment
Filing time
13 Mar 2023, 18:27:25 UTC
Date Of Original Report
08 Mar 2023
Previous filing
09 Dec 2022
Next filing
06 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Purchase $17,617,336 +16,778,415 +215% $1.05 24,573,798 08 Mar 2023 By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee. F1, F2, F3
transaction SMMT Common Stock Purchase $7,086,060 +6,748,629 +215% $1.05 9,884,095 08 Mar 2023 By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock that the Reporting Person purchased in the Issuer's rights offering.
F2 Includes the number of shares of Common Stock that were inadvertently previously disclosed as being held by Dr. Zanganeh personally, which are held by the Mahkam Zanganeh Revocable Trust. Dr. Zanganeh does not directly hold any shares personally, all of her shares are held through the Mahkam Zanganeh Revocable Trust.
F3 The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.